Versant Capital Management, Inc Vericel Corp Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Vericel Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 3 shares of VCEL stock, worth $180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
277Shares Held
48.4MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$484 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$230 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$209 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$146 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$142 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.84B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...